Survival predictors and outcomes of patients with recurrent and/or metastatic head and neck cancer treated with chemotherapy plus cetuximab as first-line therapy: A real-world retrospective study

Survival predictors and outcomes of patients with recurrent and/or metastatic head and neck cancer treated with chemotherapy plus cetuximab as first-line therapy: A real-world retrospective study

Background: In patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) the estimated prognosis is usually poor. Patient-specific factors that affect prognosis should be considered when choosing therapy. We conducted a retrospective, single-center analysis in patients...

Full description

Bibliographic Details
Main Authors: Filipa Pontes, Ana Rita Garcia, Isabel Domingues, M. João Sousa, Rita Felix, Cláudia Amorim, Fábio Salgueiro, Mónica Mariano, Margarida Teixeira
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Head and neck cancer survival predictors toxicity
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294221000733

Internet

http://www.sciencedirect.com/science/article/pii/S2468294221000733

Similar Items